SCHEDULE: Alumni Capital Discloses 9.58% Stake in Aethlon Medical

Alumni Capital LP and its affiliates have reported a 9.58% beneficial ownership stake in Aethlon Medical Inc., primarily through a Securities Purchase Agreement and warrants.

Summary

• Alumni Capital LP, Alumni Capital GP LLC, and Ashkan Mapar (collectively, "Reporting Persons") have filed a Schedule 13G, disclosing their beneficial ownership in Aethlon Medical Inc.
• The Reporting Persons collectively beneficially own 781,110 shares of Aethlon Medical Inc. common stock.
• This ownership represents 9.58% of the outstanding common stock of Aethlon Medical Inc.
• The beneficial ownership stems from a Securities Purchase Agreement, a pre-funded warrant, and a common warrant, all dated September 4, 2025.
• The reported 9.58% stake is calculated assuming an increase in the warrant ownership limitation from 4.99% to 9.99%.
• As of the filing date, Alumni Capital LP currently owns 225,555 shares and has the right to acquire an additional 161,688 shares upon exercise of outstanding common warrants, subject to the current 4.99% ownership limitation.
• The filing is made under Rule 13d-1(c), indicating a passive investment without the intent to change or influence control of the issuer.

Sentiment

Score: 6

Explanation: A significant passive institutional investment is generally a neutral to slightly positive signal, indicating investor interest and potentially providing capital to the company, without suggesting immediate operational changes or activist pressure.

Positives

• A significant institutional investor, Alumni Capital LP, has taken a substantial 9.58% stake in Aethlon Medical Inc., which can signal investor confidence in the company's prospects.
• The investment, involving a Securities Purchase Agreement and warrants, likely provided capital to Aethlon Medical Inc., supporting its operations and strategic initiatives.

Negatives

• This beneficial ownership disclosure filing does not present any explicit negative information regarding Aethlon Medical Inc.

Risks

• No specific business risks for Aethlon Medical Inc. are detailed in this beneficial ownership disclosure filing.

Future Outlook

This filing is a disclosure of current beneficial ownership and does not provide forward-looking statements or guidance from Aethlon Medical Inc. The Reporting Persons have certified that the securities were not acquired with the purpose or effect of changing or influencing control of the issuer.

Management Comments

• The securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §§ 240.14a-11.

Industry Context

The disclosure of a significant institutional stake by Alumni Capital LP in Aethlon Medical Inc. indicates continued investor interest in the healthcare or biotechnology sector, where Aethlon Medical operates. Such filings are common for passive investors acquiring over 5% of a company's shares.

Comparison to Industry Standards

• This filing is a standard Schedule 13G disclosure, indicating a passive investment. It does not contain specific performance metrics or operational results that would allow for a direct comparison to industry benchmarks or competitor performance.
• The 9.58% stake represents a substantial position for an institutional investor in a publicly traded company.

Stakeholder Impact

• Shareholders: The entry of a new significant institutional investor may be viewed positively, potentially increasing liquidity and validating the company's prospects.
• Company (Aethlon Medical Inc.): The Securities Purchase Agreement and warrants likely provided capital, supporting operations and strategic initiatives.

Next Steps

• Aethlon Medical Inc. will continue its operations, potentially utilizing the capital raised through the Securities Purchase Agreement and warrants.
• Alumni Capital LP may increase its beneficial ownership up to 9.99% by providing 61 days prior written notice or by written agreement with the Issuer, as per the warrant terms.

Key Dates

Recommendation

The filing indicates a significant institutional investor, Alumni Capital LP, has taken a 9.58% passive stake in Aethlon Medical Inc. This suggests institutional confidence and potentially provides capital to the company through the associated purchase agreement and warrants. While not a direct endorsement of operational performance, a substantial new institutional investor can be a positive signal for market sentiment. However, without further financial or operational details from Aethlon Medical, a 'hold' recommendation is appropriate, acknowledging the positive signal while awaiting more comprehensive information for a stronger stance.

Keywords

Aethlon Medical, Alumni Capital, SEC filing, Schedule 13G, beneficial ownership, common stock, institutional investment, warrants, equity stake